The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...
are going to make another attempt to win government approval of their proposed treatment for migraine headaches. Pozen said Monday morning that the two firms would submit a "full response" to the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback